DR. GEORGE JOHN BROZE, MD
Osteopathic Medicine at Parkview Pl, Saint Louis, MO
License number
Missouri R6A74
Category
Osteopathic Medicine
Type
Hematology
Address
Address
4921 Parkview Pl FLOOR 7TH, Saint Louis, MO 63110
Phone
(314) 362-8808
(314) 362-8826 (Fax)
(314) 362-8826 (Fax)
Personal information
See more information about GEORGE JOHN BROZE at radaris.comName
Address
Phone
15 W Point Ln, Saint Louis, MO 63131
Ladue, MO
15 Point Ln, Saint Louis, MO 63131
Professional information
Dr. George J Broze, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
660 S Euclid Ave SUITE 8125, Saint Louis 63110
(314) 747-3000 (Phone), (314) 362-8826 (Fax)
Saint Louis Office
660 S Euclid Ave, Saint Louis 63110
(314) 362-5000 (Phone), (314) 454-5396 (Fax)
SITEMAN CANCER CENTER
4921 Parkview Pl SUITE 7TH, Saint Louis 63110
(314) 747-1171 (Phone), (314) 362-7086 (Fax)
(314) 747-3000 (Phone), (314) 362-8826 (Fax)
Saint Louis Office
660 S Euclid Ave, Saint Louis 63110
(314) 362-5000 (Phone), (314) 454-5396 (Fax)
SITEMAN CANCER CENTER
4921 Parkview Pl SUITE 7TH, Saint Louis 63110
(314) 747-1171 (Phone), (314) 362-7086 (Fax)
Certifications:
Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Univ Of Wa Sch Of Med
Graduated: 1972
University Of Nc Hosps
Univ Of Wa Sch Of Med
Graduated: 1972
University Of Nc Hosps
George John Broze, Saint Louis MO
Specialties:
Internal Medicine, Hematology
Work:
Washington University at St. Louis
4921 Parkview Pl, Saint Louis, MO 63110 Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
4921 Parkview Pl, Saint Louis, MO 63110 Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
Education:
University of Washington (1972)
George John Broze, Saint Louis MO
Specialties:
Internist
Address:
4939 Childrens Pl, Saint Louis, MO 63110
4921 Parkview Pl, Saint Louis, MO 63110
660 S Euclid Ave, Saint Louis, MO 63110
4921 Parkview Pl, Saint Louis, MO 63110
660 S Euclid Ave, Saint Louis, MO 63110
Education:
University of Washington, School of Medicine - Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*
Method For Using Lipoprotein Associated Coagulation Inhibitor To Treat Sepsis
US Patent:
6063764, May 16, 2000
Filed:
Jun 7, 1995
Appl. No.:
8/472761
Inventors:
Abla A. Creasey - Piedmont CA
George J. Broze - Ladue MO
George J. Broze - Ladue MO
Assignee:
Washington University & Chiron Corp.
International Classification:
A61K 3800
US Classification:
514 12
Abstract:
A method for prophylactically or therapeutically treating sepsis or septic shock is described, wherein an inhibitor to tissue factor is administered to septic patients. Additionally, a method for treating inflammation is described wherein the inhibitor is administered to pateints. This inhibitor is termed lipoprotein associated coagulation inhibitor, or commonly LACI. It is 38 kD and has 276 amino acids. LACI has now been shown to be useful for the treatment of sepsis, septic shock and inflammation.
Methods And Compositions For Inhibition Of Hepatic Clearance Of Tissue Factor Pathway Inhibitor
US Patent:
5650391, Jul 22, 1997
Filed:
Mar 21, 1994
Appl. No.:
8/216593
Inventors:
Alan L. Schwartz - Clayton MO
Ilka Warshawsky - St. Louis MO
George J. Broze - Ladue MO
Ilka Warshawsky - St. Louis MO
George J. Broze - Ladue MO
Assignee:
Jewish Hospital of St. Louis - St. Louis MO
International Classification:
A61K 3816
US Classification:
514 12
Abstract:
The present invention discloses methods and compositions for inhibiting the hepatic clearance of Tissue Factor Pathway Inhibitor (TFPI) using receptor-associated protein.
Method For Using Lipoprotein Associated Coagulation Inhibitor To Treat Sepsis
US Patent:
7662774, Feb 16, 2010
Filed:
Jul 15, 2004
Appl. No.:
10/891493
Inventors:
Abla A. Creasey - Piedmont CA, US
George J. Broze - Ladue MO, US
George J. Broze - Ladue MO, US
Assignee:
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
C07K 14/00
US Classification:
514 2, 530350
Abstract:
A method for prophylactically or therapeutically treating sepsis or septic shock is described, wherein an inhibitor to tissue factor is administered to septic patients. Additionally, a method for treating inflammation is described wherein the inhibitor is administered to patients. This inhibitor is termed lipoprotein associated coagulation inhibitor, or commonly LACI. It is 38 kD and has 276 amino acids. LACI has now been shown to be useful for the treatment of sepsis, septic shock and inflammation.